89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
8.88
-0.35 (-3.79%)
At close: Mar 3, 2025, 4:00 PM
8.98
+0.10 (1.13%)
After-hours: Mar 3, 2025, 6:58 PM EST
89bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 39.62 | 28.97 | 21.45 | 19.41 | 13.16 | |
| Research & Development | 345.04 | 122.23 | 80.8 | 70.33 | 36.2 | |
| Operating Expenses | 384.66 | 151.2 | 102.25 | 89.74 | 49.36 | |
| Operating Income | -384.66 | -151.2 | -102.25 | -89.74 | -49.36 | |
| Interest Expense | -5.29 | -4.79 | -1.92 | -0.67 | - | |
| Interest & Investment Income | 13.59 | 11.43 | 1.18 | 1.01 | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.07 | |
| EBT Excluding Unusual Items | -376.36 | -144.56 | -102.99 | -89.4 | -49.29 | |
| Gain (Loss) on Sale of Investments | 9.97 | 6.24 | 0.98 | -0.87 | -0.27 | |
| Pretax Income | -366.39 | -138.32 | -102.01 | -90.27 | -49.56 | |
| Income Tax Expense | 0.69 | 3.87 | 0.02 | -0.15 | -0.06 | |
| Net Income | -367.08 | -142.19 | -102.03 | -90.12 | -49.5 | |
| Net Income to Common | -367.08 | -142.19 | -102.03 | -90.12 | -49.5 | |
| Shares Outstanding (Basic) | 105 | 71 | 35 | 20 | 16 | |
| Shares Outstanding (Diluted) | 105 | 71 | 35 | 20 | 16 | |
| Shares Change (YoY) | 47.13% | 104.48% | 73.18% | 24.93% | 586.28% | |
| EPS (Basic) | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 | |
| EPS (Diluted) | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 | |
| Free Cash Flow | -367.84 | -129.19 | -81.1 | -76.84 | -46.37 | |
| Free Cash Flow Per Share | -3.51 | -1.82 | -2.33 | -3.82 | -2.88 | |
| EBITDA | -384.62 | -151.15 | -102.18 | -89.66 | -49.3 | |
| D&A For EBITDA | 0.04 | 0.05 | 0.07 | 0.08 | 0.06 | |
| EBIT | -384.66 | -151.2 | -102.25 | -89.74 | -49.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.